Acute action of rotenone on nigral dopaminergic neurons--involvement of reactive oxygen species and disruption of Ca2+ homeostasis

Eur J Neurosci. 2009 Nov;30(10):1849-59. doi: 10.1111/j.1460-9568.2009.06990.x. Epub 2009 Nov 11.

Abstract

Rotenone is a toxin used to generate animal models of Parkinson's disease; however, the mechanisms of toxicity in substantia nigra pars compacta (SNc) neurons have not been well characterized. We have investigated rotenone (0.05-1 microm) effects on SNc neurons in acute rat midbrain slices, using whole-cell patch-clamp recording combined with microfluorometry. Rotenone evoked a tolbutamide-sensitive outward current (94 +/- 15 pA) associated with increases in intracellular [Ca(2+)] ([Ca(2+)](i)) (73.8 +/- 7.7 nm) and intracellular [Na(+)] (3.1 +/- 0.6 mm) (all with 1 microm). The outward current was not affected by a high ATP level (10 mm) in the patch pipette but was decreased by Trolox. The [Ca(2+)](i) rise was abolished by removing extracellular Ca(2+), and attenuated by Trolox and a transient receptor potential M2 (TRPM2) channel blocker, N-(p-amylcinnamoyl) anthranilic acid. Other effects included mitochondrial depolarization (rhodamine-123) and increased mitochondrial reactive oxygen species (ROS) production (MitoSox), which was also abolished by Trolox. A low concentration of rotenone (5 nm) that, by itself, did not evoke a [Ca(2+)](i) rise resulted in a large (46.6 +/- 25.3 nm) Ca(2+) response when baseline [Ca(2+)](i) was increased by a 'priming' protocol that activated voltage-gated Ca(2+) channels. There was also a positive correlation between 'naturally' occurring variations in baseline [Ca(2+)](i) and the rotenone-induced [Ca(2+)](i) rise. This correlation was not seen in non-dopaminergic neurons of the substantia nigra pars reticulata (SNr). Our results show that mitochondrial ROS production is a key element in the effect of rotenone on ATP-gated K(+) channels and TRPM2-like channels in SNc neurons, and demonstrate, in these neurons (but not in the SNr), a large potentiation of rotenone-induced [Ca(2+)](i) rise by a small increase in baseline [Ca(2+)](i).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Antioxidants / pharmacology
  • Biophysical Phenomena / drug effects
  • Biophysics
  • Calcium / metabolism*
  • Chromans / pharmacology
  • Cinnamates / pharmacology
  • Clusterin / antagonists & inhibitors
  • Dopamine / metabolism*
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Electric Stimulation
  • Female
  • Flufenamic Acid / pharmacology
  • Homeostasis / drug effects
  • In Vitro Techniques
  • Insecticides / pharmacology*
  • Male
  • Membrane Potential, Mitochondrial / drug effects
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Neurons / drug effects*
  • Neurons / metabolism
  • Patch-Clamp Techniques / methods
  • Rats
  • Rats, Wistar
  • Reactive Oxygen Species / metabolism*
  • Rotenone / pharmacology*
  • Sodium / metabolism
  • Substantia Nigra / cytology*
  • Substantia Nigra / drug effects
  • Tolbutamide / pharmacology
  • ortho-Aminobenzoates / pharmacology

Substances

  • Antioxidants
  • Chromans
  • Cinnamates
  • Clusterin
  • Insecticides
  • Reactive Oxygen Species
  • ortho-Aminobenzoates
  • Rotenone
  • 4-amylcinnamoylanthranilic acid
  • Flufenamic Acid
  • Adenosine Triphosphate
  • Tolbutamide
  • Sodium
  • 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
  • Calcium
  • Dopamine